Compounded peptides placed on restrictive list by FDA, lawsuit filed
The FDA is evaluating the future of compounded peptides, which are popular short-chain amino acids that signal cells to perform specific biological functions like reducing inflammation, aiding tissue…
Read the full articleYou might also wanna read
RFK Jr. pushes peptide deregulation; FDA scientists cite lack of safety evidence
The health secretary has advocated for deregulating more peptides, but FDA scientists point to a lack of data about their safety and effecti
nbcnews.to·10d ago
FDA PCAC Hearing July 2026: What's at Stake for Compounded Peptide Access
Follow the July 23-24, 2026 FDA hearing on peptide compounding, get hearing updates, and tell the FDA your position before the comment deadl
pepmed.org·9d ago
FDA to discuss easing restrictions on peptides despite safety concerns
Committee will meet in July to discuss peptides now sold in gray market despite limited evidence of safety and efficacy Advisers to the Food
FDA Announces Plans to Restrict Non-Approved GLP-1 Drugs in Compounded Medications
Today, the U.S. Food and Drug Administration is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredi
fda.gov·5mo ago
FDA Scientists Find Insufficient Evidence for Peptides, Undercutting RFK Jr.'s Push for Expanded Access
RFK Jr. recently added peptide-friendly members to a key panel
medpagetoday.com·9d ago
FDA Drops the Hammer on the Gray Market Peptide Craze: A Deep Dive into the July 2026 Pharmacy Compounding Advisory Committee Meeting
🎧 Part I Podcast free on Spotify.
Comments
Sign in to join the conversation.
No comments yet. Be the first.